Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-005871
Filing Date
2025-04-23
Accepted
2025-04-23 16:51:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 757612
2 ex4-15.htm EX-4.15 99866
3 ex10-33.htm EX-10.33 238052
4 ex23-1.htm EX-23.1 4299
5 formdrs_001.jpg GRAPHIC 18919
6 formdrs_002.jpg GRAPHIC 76389
7 formdrs_003.jpg GRAPHIC 53358
8 formdrs_004.jpg GRAPHIC 63611
  Complete submission text file 0001641172-25-005871.txt   1393692
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: S-1/A | Act: 33 | File No.: 333-286670 | Film No.: 25862239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)